Tobacco

Citations 111-120 of 219 total displayed.

Past content (since Feb 1998):

Original Contributions
Varenicline, an 42 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation: A Randomized Controlled Trial

David Gonzales; Stephen I. Rennard; Mitchell Nides; Cheryl Oncken; Salomon Azoulay; Clare B. Billing; Eric J. Watsky; Jason Gong; Kathryn E. Williams; Karen R. Reeves; for the Varenicline Phase 3 Study Group
JAMA 2006; 296: 47-55. [Abstract] [Full text] [PDF] [ Author in the Room Audio ]  

Original Contributions
Efficacy of Varenicline, an 42 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation: A Randomized Controlled Trial

Douglas E. Jorenby; J. Taylor Hays; Nancy A. Rigotti; Salomon Azoulay; Eric J. Watsky; Kathryn E. Williams; Clare B. Billing; Jason Gong; Karen R. Reeves; for the Varenicline Phase 3 Study Group
JAMA 2006; 296: 56-63. [Abstract] [Full text] [PDF]  

Original Contributions
Effect of Maintenance Therapy With Varenicline on Smoking Cessation: A Randomized Controlled Trial

Serena Tonstad; Philip Tønnesen; Peter Hajek; Kathryn E. Williams; Clare B. Billing; Karen R. Reeves; for the Varenicline Phase 3 Study Group
JAMA 2006; 296: 64-71. [Abstract] [Full text] [PDF]  

Editorials
Varenicline for Smoking Cessation: Definite Promise, But No Panacea

Robert C. Klesges; Karen C. Johnson; Grant Somes
JAMA 2006; 296: 94-95. [Extract] [Full text] [PDF]  

JAMA Patient Page
Smoking Cessation

Erin Brender; Cassio Lynm; Richard M. Glass
JAMA 2006; 296: 130. [Extract] [Full text] [PDF] [ Spanish PDF ]  

From the Centers for Disease Control and Prevention
Use of Cigarettes and Other Tobacco Products Among Students Aged 13-15 Years—Worldwide, 1999-2005

JAMA 2006; 295: 2842-2843. [Extract] [Full text] [PDF]  

Letters
The Rehnquist Court and Tobacco

James H. Lutschg
JAMA 2006; 295: 1250-b-1251-b. [Extract] [Full text] [PDF]  

Letters
The Rehnquist Court and Tobacco—Reply

Lawrence O. Gostin
JAMA 2006; 295: 1251. [Extract] [Full text] [PDF]  

Letters
Smoking Reduction and Lung Cancer Risk—Reply

Nina S. Godtfredsen
JAMA 2006; 295: 1001-a-1002-a. [Extract] [Full text] [PDF]  

Letters
Smoking Reduction and Lung Cancer Risk

Jeffrey Berger
JAMA 2006; 295: 1001. [Extract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22